Home > News > pSivida to gets approval to test cancer cure on humans
April 26th, 2004
pSivida to gets approval to test cancer cure on humans
Abstract:
Global nanotechnology company pSivida Limited (PSD) today announced that its Singapore subsidiary has obtained all the necessary approvals to commence Phase IIa human clinical trials for its lead brachytherapy product, BrachySilT. The 12 week trial is scheduled to commence in May and will be conducted by Singapore’s National Cancer Centre (“NCC”).
Source:
egoli
Bookmark:
| Related News Press |
Nanomedicine
Diamond glitter: A play of colors with artificial DNA crystals May 17th, 2024
Advances in priming B cell immunity against HIV pave the way to future HIV vaccines, shows quartet of new studies May 17th, 2024
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||